Skip to main content

Advertisement

SpringerLink
Log in

Incidental primary breast cancer detected on PET–CT

  • Review
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The purpose of this study is to determine the incidence of primary breast cancer (PBC) detected on (18) F-fluorodeoxyglucose (FDG) positron emission tomography (PET)–computed tomography (CT) in patients with a known diagnosis of non-mammary malignancies. A database search was performed to identify patients with non-mammary malignancies who had undergone staging with FDG PET–CT at a single institution between September 2005 and September 2011 and with the word “breast” reported in the PET–CT dictation. Additional breast imaging studies, clinical data, and the final histopathology of the breast lesions were correlated with the PET–CT images. Of 1951 patients who underwent PET/CT, 440 incidental breast lesions were identified in 438 patients. Of these 440 lesions, 195 (45 %) were benign, 160 (37 %) malignant, and 85 (19 %) missing data. A total of 25 PBCs were diagnosed; with a median size of 1.8 cm (range 0.8–10.7 cm); and a median SUVmax of 4.4 (range 1.7–17.6). There were 19 invasive ductal cancers, 1 invasive lobular cancer, 2 papillary cancers, 1 tubular cancer, 1 sarcomatoid cancer, and 1 ductal carcinoma in situ. Eight patients had regional nodal disease. Mammography revealed the PBC in 19 of 23 tumors (83 %), sonography in 22 of 23 (96 %). Six percent (25 of 440) of incidental breast lesions identified on FDG PET–CT represent PBCs; more than half were at an early stage and potentially curable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Avril N et al (2000) Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations. J Clin Oncol 18(20):3495–3502

    CAS  PubMed  Google Scholar 

  2. Bar-Shalom R, Valdivia AY, Blaufox MD (2000) PET imaging in oncology. Semin Nucl Med 30(3):150–185

    Article  CAS  PubMed  Google Scholar 

  3. Bohuslavizki KH et al (2000) FDG PET detection of unknown primary tumors. J Nucl Med 41(5):816–822

    CAS  PubMed  Google Scholar 

  4. Eubank WB, Mankoff DA (2005) Evolving role of positron emission tomography in breast cancer imaging. Semin Nucl Med 35(2):84–99

    Article  PubMed  Google Scholar 

  5. Kostakoglu L, Agress H Jr, Goldsmith SJ (2003) Clinical role of FDG PET in evaluation of cancer patients. Radiographics 23(2):315–340

    Article  PubMed  Google Scholar 

  6. Shen YY et al (2003) The value of 18F-fluorodeoxyglucose positron emission tomography with the additional help of tumor markers in cancer screening. Neoplasma 50(3):217–221

    CAS  PubMed  Google Scholar 

  7. Yasuda S et al (2000) Application of positron emission tomography imaging to cancer screening. Br J Cancer 83(12):1607–1611

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Dong C, Hemminki K (2001) Second primary neoplasms among 53 159 haematolymphoproliferative malignancy patients in Sweden, 1958–1996: a search for common mechanisms. Br J Cancer 85(7):997–1005

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Ishimori T, Patel PV, Wahl RL (2005) Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med 46(5):752–757

    PubMed  Google Scholar 

  10. Ueno M et al (2003) Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer. Int J Clin Oncol 8(3):162–167

    Article  PubMed  Google Scholar 

  11. Sickles E, D’Orsi CJ, Bassett LW et al (2013) ACR BI-RADS® Mammography. ACR BI-RADS® atlas, breast imaging reporting and data system. American College of Radiology, Washington, DC

    Google Scholar 

  12. Mendelson EB, Böhm-Vélez M, Berg WA et al (2013) ACR BI-RADS® ultrasound. ACR BI-RADS® atlas, breast imaging reporting and data system. American College of Radiology, Reston

    Google Scholar 

  13. Morris EA, Comstock CE, Lee CH et al (2013) ACR BI-RADS® Magnetic Resonance Imaging. Atlas, Breast Imaging Reporting and Data System. American College of Radiology, Reston

    Google Scholar 

  14. Kumar R et al (2006) Standardized uptake values of normal breast tissue with 2-deoxy-2-[F-18]fluoro-d: -glucose positron emission tomography: variations with age, breast density, and menopausal status. Mol Imaging Biol 8(6):355–362

    Article  PubMed  Google Scholar 

  15. Lin CY et al (2007) Correlation between the intensity of breast FDG uptake and menstrual cycle. Acad Radiol 14(8):940–944

    Article  PubMed  Google Scholar 

  16. Vranjesevic D et al (2003) Relationship between 18F-FDG uptake and breast density in women with normal breast tissue. J Nucl Med 44(8):1238–1242

    PubMed  Google Scholar 

  17. Harish MG et al (2007) Breast lesions incidentally detected with CT: what the general radiologist needs to know. Radiographics 27(Suppl 1):S37–S51

    Article  PubMed  Google Scholar 

  18. Korn RL et al (2006) Unexpected focal hypermetabolic activity in the breast: significance in patients undergoing 18F-FDG PET/CT. AJR Am J Roentgenol 187(1):81–85

    Article  PubMed  Google Scholar 

  19. McDonough MD, DePeri ER, Mincey BA (2004) The role of positron emission tomographic imaging in breast cancer. Curr Oncol Rep 6(1):62–68

    Article  PubMed  Google Scholar 

  20. Henschke CI et al (2006) Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med 355(17):1763–1771

    Article  PubMed  Google Scholar 

  21. Avril N (2007) Adler LP, F-18 fluorodeoxyglucose-positron emission tomography imaging for primary breast cancer and loco-regional staging. Radiol Clin North Am 45(4):645–657

    Article  PubMed  Google Scholar 

  22. Rosé C, Dose J, Avril N (2002) Positron emission tomography for the diagnosis of breast cancer. Nucl Med Commun 23:613–618

    Article  PubMed  Google Scholar 

  23. Schilling K et al (2011) Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging. Eur J Nucl Med Mol Imaging 38(1):23–36

    Article  PubMed Central  PubMed  Google Scholar 

  24. Weinberg IN et al (2005) Positron emission mammography: high-resolution biochemical breast imaging. Technol Cancer Res Treat 4(1):55–60

    Article  PubMed  Google Scholar 

  25. Berg WA et al (2006) High-resolution fluorodeoxyglucose positron emission tomography with compression (“positron emission mammography”) is highly accurate in depicting primary breast cancer. Breast J 12(4):309–323

    Article  PubMed  Google Scholar 

  26. Brem RF et al (2007) Breast-specific gamma imaging with 99mTc-Sestamibi and magnetic resonance imaging in the diagnosis of breast cancer–a comparative study. Breast J 13(5):465–469

    Article  PubMed  Google Scholar 

Download references

Disclosure

Benveniste AP, MD, Marom EM, MD, Benveniste MF, MD, Mawlawi O, PhD have nothing to disclose. Fox PS, MS—NCI Grant to Institution. Yang WT, MD—Toshiba/Seno Medical [Consultant/Advisory].

Author information

Authors and Affiliations

  1. Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1459, Houston, TX, 77030, USA

    A. P. Benveniste, E. M. Marom, M. F. Benveniste & Wei Yang

  2. Department of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA

    O. Mawlawi

  3. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA

    P. S. Fox

Authors
  1. A. P. Benveniste
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. M. Marom
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. F. Benveniste
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. O. Mawlawi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. S. Fox
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Wei Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wei Yang.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Benveniste, A.P., Marom, E.M., Benveniste, M.F. et al. Incidental primary breast cancer detected on PET–CT. Breast Cancer Res Treat 151, 261–268 (2015). https://doi.org/10.1007/s10549-015-3402-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-015-3402-7

Keywords

Search

Navigation